Svelte Medical Systems Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Out of Business

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Out of Business

Svelte Medical Systems General Information

Description

Developer of drug-eluting coronary stent-on-a-wire Integrated delivery system designed to treat coronary artery disease. The company's device incorporates specialized guide wire tip technology and its proprietary balloon enhances direct stenting and navigates coronary arteries like a guide wire, thereby eliminating the need for additional guide wires and balloons in most cases, enabling patients to experience better clinical outcomes, enhanced comfort and reduced time and cost of procedures.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 675 Central Avenue
  • New Providence, NJ 07974
  • United States
+1 (908)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 675 Central Avenue
  • New Providence, NJ 07974
  • United States
+1 (908)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Svelte Medical Systems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Out of Business 01-Apr-2023 Completed Out of Business
9. Secondary Transaction - Private 01-Aug-2021 Completed Generating Revenue
8. Later Stage VC (Series C) 23-Apr-2021 Completed Generating Revenue
7. Later Stage VC (Series B3) 21-Jan-2019 Completed Generating Revenue
6. Later Stage VC (Series B2) 21-Nov-2017 Completed Generating Revenue
5. Later Stage VC (Series B) 25-Jul-2016 Completed Generating Revenue
4. Later Stage VC 10-Mar-2014 Completed Generating Revenue
3. Early Stage VC (Series B) 14-Dec-2011 Completed Generating Revenue
2. Early Stage VC (Series A) 07-Dec-2009 $6M $20M Completed Generating Revenue
1. Early Stage VC (Series A) 15-May-2009 $14M $14M Completed Generating Revenue
To view Svelte Medical Systems’s complete valuation and funding history, request access »

Svelte Medical Systems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B3
Series B2
Series B1
Series A1 10,848 $0.001000 8% $1000 $1000 1x $1000 0.97%
Series A 42,296 $0.001000 8% $1000 $1000 1x $1000 3.77%
To view Svelte Medical Systems’s complete cap table history, request access »

Svelte Medical Systems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of drug-eluting coronary stent-on-a-wire Integrated delivery system designed to treat coronary artery disease.
Therapeutic Devices
New Providence, NJ
22 As of 2016

San Diego, CA
 

Deerfield, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Svelte Medical Systems Competitors (4)

One of Svelte Medical Systems’s 4 competitors is DexCom, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DexCom Formerly VC-backed San Diego, CA
Baxter International Corporation Deerfield, IL
R3 Vascular Venture Capital-Backed Mountain View, CA
Biotronik Corporate Backed or Acquired Berlin, Germany
To view Svelte Medical Systems’s complete competitors history, request access »

Svelte Medical Systems Patents

Svelte Medical Systems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20150238338-A1 Preventing embolization of drug eluting stents Active 15-Dec-2010
US-9241817-B2 Preventing embolization of drug eluting stents Inactive 15-Dec-2010
EP-2651346-A2 A stent delivery catheter Inactive 15-Dec-2010
US-20120158116-A1 Means and method for preventing embolization of drug eluting stents Active 15-Dec-2010
US-20120150271-A1 Buddy wire for the coronary arteries Inactive 09-Dec-2010 A61M25/09
To view Svelte Medical Systems’s complete patent history, request access »

Svelte Medical Systems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Svelte Medical Systems Investments (1)

Svelte Medical Systems’s most recent deal was a Early Stage VC with Ostial Solutions for . The deal was made on 08-Sep-2010.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ostial Solutions 08-Sep-2010 Early Stage VC Therapeutic Devices
To view Svelte Medical Systems’s complete investments history, request access »

Svelte Medical Systems FAQs

  • When was Svelte Medical Systems founded?

    Svelte Medical Systems was founded in 2007.

  • Where is Svelte Medical Systems headquartered?

    Svelte Medical Systems is headquartered in New Providence, NJ.

  • What is the size of Svelte Medical Systems?

    Svelte Medical Systems has 22 total employees.

  • What industry is Svelte Medical Systems in?

    Svelte Medical Systems’s primary industry is Therapeutic Devices.

  • Is Svelte Medical Systems a private or public company?

    Svelte Medical Systems is a Private company.

  • What is Svelte Medical Systems’s current revenue?

    The current revenue for Svelte Medical Systems is .

  • How much funding has Svelte Medical Systems raised over time?

    Svelte Medical Systems has raised $172M.

  • Who are Svelte Medical Systems’s competitors?

    DexCom, Baxter International, R3 Vascular, and Biotronik are competitors of Svelte Medical Systems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »